Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Zubizarreta I, Flórez-Grau G, Vila G, Cabezón R, España C, Andorra M, Saiz A, Llufriu S, Sepulveda M, Sola-Valls N, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Casanova B, Martinez Gines M, Tellez N, Oreja-Guevara C, Español M, Trias E, Cid J, Juan M, Lozano M, Blanco Y, Steinman L, Benitez-Ribas D, Villoslada P.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8463-8470. doi: 10.1073/pnas.1820039116. Epub 2019 Apr 8.

2.

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.

Flórez-Grau G, Zubizarreta I, Cabezón R, Villoslada P, Benitez-Ribas D.

Front Immunol. 2018 May 31;9:1169. doi: 10.3389/fimmu.2018.01169. eCollection 2018. Review.

3.

Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.

Benitez-Ribas D, Cabezón R, Flórez-Grau G, Molero MC, Puerta P, Guillen A, González-Navarro EA, Paco S, Carcaboso AM, Santa-Maria Lopez V, Cruz O, de Torres C, Salvador N, Juan M, Mora J, Morales La Madrid A.

Front Oncol. 2018 Jun 5;8:201. doi: 10.3389/fonc.2018.00201. eCollection 2018.

4.

Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.

Benitez-Ribas D, Cabezón R, Flórez-Grau G, Molero MC, Puerta P, Guillen A, Paco S, Carcaboso AM, Santa-Maria Lopez V, Cruz O, de Torres C, Salvador N, Juan M, Mora J, La Madrid AM.

Front Oncol. 2018 Apr 26;8:127. doi: 10.3389/fonc.2018.00127. eCollection 2018. Erratum in: Front Oncol. 2018 Jun 05;8:201.

5.

Exhaustive search for epistatic effects on the human methylome.

Egli T, Vukojevic V, Sengstag T, Jacquot M, Cabezón R, Coynel D, Freytag V, Heck A, Vogler C, de Quervain DJ, Papassotiropoulos A, Milnik A.

Sci Rep. 2017 Oct 20;7(1):13669. doi: 10.1038/s41598-017-13256-9.

6.

Up-regulation of EP2 and EP3 receptors in human tolerogenic dendritic cells boosts the immunosuppressive activity of PGE2.

Flórez-Grau G, Cabezón R, Borgman KJE, España C, Lozano JJ, Garcia-Parajo MF, Benítez-Ribas D.

J Leukoc Biol. 2017 Sep;102(3):881-895. doi: 10.1189/jlb.2A1216-526R. Epub 2017 Jun 19.

PMID:
28630103
7.

Nanoencapsulated budesonide in self-stratified polyurethane-polyurea nanoparticles is highly effective in inducing human tolerogenic dendritic cells.

Flórez-Grau G, Rocas P, Cabezón R, España C, Panés J, Rocas J, Albericio F, Benítez-Ribas D.

Int J Pharm. 2016 Sep 25;511(2):785-93. doi: 10.1016/j.ijpharm.2016.07.056. Epub 2016 Jul 28.

PMID:
27477102
8.

New insights into the phenotype of human dendritic cell populations.

Clark GJ, Kupresanin F, Fromm PD, Ju X, Muusers L, Silveira PA, Elgundi Z, Gasiorowski RE, Papadimitrious MS, Bryant C, Lee KM, Clarke CJ, Young JW, Chan A, Harman A, Botting R, Cabezón R, Benitez-Ribas D, Brooks AE, Dunbar PR, Hart DN.

Clin Transl Immunology. 2016 Jan 29;5(1):e61. doi: 10.1038/cti.2015.40. eCollection 2016 Jan.

9.

Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study.

Jauregui-Amezaga A, Cabezón R, Ramírez-Morros A, España C, Rimola J, Bru C, Pinó-Donnay S, Gallego M, Masamunt MC, Ordás I, Lozano M, Cid J, Panés J, Benítez-Ribas D, Ricart E.

J Crohns Colitis. 2015 Dec;9(12):1071-8. doi: 10.1093/ecco-jcc/jjv144. Epub 2015 Aug 24.

PMID:
26303633
10.

MERTK as negative regulator of human T cell activation.

Cabezón R, Carrera-Silva EA, Flórez-Grau G, Errasti AE, Calderón-Gómez E, Lozano JJ, España C, Ricart E, Panés J, Rothlin CV, Benítez-Ribas D.

J Leukoc Biol. 2015 Apr;97(4):751-60. doi: 10.1189/jlb.3A0714-334R. Epub 2015 Jan 26.

11.

In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells.

Crisci E, Fraile L, Novellas R, Espada Y, Cabezón R, Martínez J, Cordoba L, Bárcena J, Benitez-Ribas D, Montoya M.

Mol Immunol. 2015 Feb;63(2):343-54. doi: 10.1016/j.molimm.2014.08.006. Epub 2014 Oct 1.

PMID:
25282042
12.

Priming by chemokines restricts lateral mobility of the adhesion receptor LFA-1 and restores adhesion to ICAM-1 nano-aggregates on human mature dendritic cells.

Borgman KJ, van Zanten TS, Manzo C, Cabezón R, Cambi A, Benítez-Ribas D, Garcia-Parajo MF.

PLoS One. 2014 Jun 19;9(6):e99589. doi: 10.1371/journal.pone.0099589. eCollection 2014.

13.

Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application.

Cabezón R, Benítez-Ribas D.

Clin Dev Immunol. 2013;2013:789814. doi: 10.1155/2013/789814. Epub 2013 Nov 12. Review.

14.

Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells.

Cabezón R, Ricart E, España C, Panés J, Benitez-Ribas D.

PLoS One. 2012;7(12):e52456. doi: 10.1371/journal.pone.0052456. Epub 2012 Dec 27.

15.

Effect of intravenous fluid therapy on postoperative vomiting in children undergoing tonsillectomy.

Elgueta MF, Echevarría GC, De la Fuente N, Cabrera F, Valderrama A, Cabezón R, Muñoz HR, Cortinez LI.

Br J Anaesth. 2013 Apr;110(4):607-14. doi: 10.1093/bja/aes453. Epub 2012 Dec 19.

16.

Chimeric calicivirus-like particles elicit specific immune responses in pigs.

Crisci E, Fraile L, Moreno N, Blanco E, Cabezón R, Costa C, Mussá T, Baratelli M, Martinez-Orellana P, Ganges L, Martínez J, Bárcena J, Montoya M.

Vaccine. 2012 Mar 23;30(14):2427-39. doi: 10.1016/j.vaccine.2012.01.069. Epub 2012 Feb 3.

PMID:
22306796
17.

Analysis of HLDA9 mAbs on plasmacytoid dendritic cells.

Cabezón R, Sintes J, Llinàs L, Benitez-Ribas D.

Immunol Lett. 2011 Jan 30;134(2):167-73. doi: 10.1016/j.imlet.2010.09.020. Epub 2010 Oct 7.

PMID:
20933012
18.

Evaluation of cervical dysplasia treatment by large loop excision of the transformation zone (LLETZ). Does completeness of excision determine outcome?

de Cabezón RH, Sala CV, Gomis SS, Lliso AR, Bellvert CG.

Eur J Obstet Gynecol Reprod Biol. 1998 May;78(1):83-9.

PMID:
9605455

Supplemental Content

Loading ...
Support Center